Using NAL-NL3 in clinical practice: a modular NAL fitting system for real-world listening needs.

Authors

Matthew Croteau, Catherine Kwok

Published in

International journal of audiology. Pages 1-13. Jun 27, 2026. Epub Jun 27, 2026.

Abstract

To provide hearing care professionals (HCPs) with an overview of the NAL-NL3 fitting system and to guide its use in clinical practice. The aim is to translate the research underpinning NAL-NL3 into practical guidance.
This Clinical Note outlines the rationale and clinical application of the NAL-NL3 fitting system, which at launch comprises the NAL-NL3 Prescription, the Comfort in Noise (CIN) Module, and the Minimal Hearing Loss (MHL) Module.
The NAL-NL3 fitting system was developed through laboratory and field testing and feedback from hearing care professionals. The NAL-NL3 Prescription provides amplification that aligns more closely with clinical needs, improving first-fit satisfaction and clinical efficiency for a wider range of cases. The Comfort in Noise Module offers a comfort-focused amplification profile adapted for noisy environments, improving comfort and reducing listening fatigue while maintaining speech intelligibility. The Minimal Hearing Loss Module extends hearing aid fitting to adults with normal or near-normal hearing thresholds who experience hearing difficulties, providing safe access to hearing aid technologies.
NAL-NL3 is the next generation of NAL's evidence-based philosophy towards prescribing hearing aid amplification. Its modular design enables hearing care professionals to better personalise fittings to patients' communication needs, supporting patient-centred care.

PMID:
42363720
Bibliographic data and abstract were imported from PubMed on 27 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.